HLS vs MYX

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

HLS

HEALIUS FPO [HLS]

54MEDIUM

MYX

M PHARMA FPO [MYX]

51MEDIUM

Score Breakdown

HLS MYX
Technical
68
51
Catalyst
87
53
Sentiment
50
50
Fundamental
90
85
Momentum
34
38
Risk Gate
32
42

Key Metrics

HLS Metric MYX
$275.9MMarket Cap$233.2M
4.3MAvg Volume (20d)291K
+10.1%Short Interest+2.5%
$1.07052-Week High$6.500
$0.30052-Week Low$2.040
+3.2%Daily Change-0.7%
$0.392Reference Price$2.810
-69.3%ROE-20.6%
-12.3%Profit Margin-20.4%

Active Signals

HLS Signals

●MACD momentum is picking up steam
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Trading above both moving averages — the trend is your friend here
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.2x)
●EPS estimates revised upward (+10pts)
●Near 52-week low (10% of range)

MYX Signals

●Beating the Small Ords index — relative strength of 1.29, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.6x)
●EPS estimates revised upward (+10pts)
●Near 52-week low (19% of range)
●CANSLIM I: Institutional ownership (36%)
●Deeply negative margins (-20%)

Ask Scout AI to compare HLS and MYX in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

HLS vs NOX →HLS vs NUZ →HLS vs NXN →HLS vs PAR →HLS vs PCK →
HLS Full Analysis → MYX Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).